Effects of Pulmonary Rehabilitation in Patients with Non-Cystic Fibrosis Bronchiectasis

A Retrospective Analysis of Clinical and Functional Predictors of Efficacy

Andrea Zanini, Marina Aiello, Daniela Adamo, Francesca Cherubino, Elisabetta Zampogna, Giovanni Sotgiu, Alfredo Chetta, Antonio Spanevello

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Background: International guidelines recommend the inclusion of patients with bronchiectasis in pulmonary rehabilitation (PR) to improve exercise capacity and health-related quality of life (HRQoL). At present, the effect of PR in these patients has been poorly investigated. Objective: The aim of our retrospective analysis was to evaluate the effects and predictors of success for a PR program in patients with bronchiectasis not related to cystic fibrosis (non-CF bronchiectasis). Methods: One hundred and thirty-five non-CF bronchiectasis inpatients, allocated to a 3-week PR program, were retrospectively evaluated. Exercise capacity (6-min walk distance, 6MWD), dyspnea (Baseline/Transition Dyspnea Index, BDI/TDI), and HRQoL [EuroQol visual analogue scale (EQ-VAS)] were assessed before and after PR. The relationship between baseline parameters and changes in outcome measures after PR was assessed. Both univariate and multiple logistic analyses were performed to evaluate the presence of independent predictors of the efficacy of PR. Results: One hundred and eight patients [49 males, mean age 71 years, mean forced expiratory volume in 1 s (FEV1) 76% predicted] were included. After PR, there was a significant improvement in 6MWD, TDI, and EQ-VAS score (p <0.001). Changes in 6MWD and EQ-VAS score correlated with baseline FEV1, FEV1/vital capacity (VC), residual volume, transfer factor of the lung for carbon monoxide, and the number of exacerbations in the previous year. Both univariate and multivariate logistic regression analyses showed that male gender, baseline FEV1/VC 2 exacerbations in the previous year were independent predictors of PR efficacy in terms of an improvement in 6MWD. Conclusions: Our study supports the inclusion of patients with bronchiectasis in PR programs. Clinical and functional baseline findings partially predict the response to PR in terms of exercise tolerance. Further prospective, randomized, controlled trials are needed.

Original languageEnglish
Pages (from-to)525-533
Number of pages9
JournalRespiration
Volume89
Issue number6
DOIs
Publication statusPublished - Jul 22 2015

Fingerprint

Bronchiectasis
Fibrosis
Rehabilitation
Lung
Forced Expiratory Volume
Visual Analog Scale
Vital Capacity
Dyspnea
Quality of Life
Exercise
Transfer Factor
Residual Volume
Exercise Tolerance
Carbon Monoxide
Cystic Fibrosis
Inpatients
Randomized Controlled Trials
Logistic Models
Regression Analysis
Outcome Assessment (Health Care)

Keywords

  • Bronchiectasis
  • Predictors of efficacy
  • Pulmonary rehabilitation

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Effects of Pulmonary Rehabilitation in Patients with Non-Cystic Fibrosis Bronchiectasis : A Retrospective Analysis of Clinical and Functional Predictors of Efficacy. / Zanini, Andrea; Aiello, Marina; Adamo, Daniela; Cherubino, Francesca; Zampogna, Elisabetta; Sotgiu, Giovanni; Chetta, Alfredo; Spanevello, Antonio.

In: Respiration, Vol. 89, No. 6, 22.07.2015, p. 525-533.

Research output: Contribution to journalArticle

@article{49978c01c3614defa4b7495875c50fcd,
title = "Effects of Pulmonary Rehabilitation in Patients with Non-Cystic Fibrosis Bronchiectasis: A Retrospective Analysis of Clinical and Functional Predictors of Efficacy",
abstract = "Background: International guidelines recommend the inclusion of patients with bronchiectasis in pulmonary rehabilitation (PR) to improve exercise capacity and health-related quality of life (HRQoL). At present, the effect of PR in these patients has been poorly investigated. Objective: The aim of our retrospective analysis was to evaluate the effects and predictors of success for a PR program in patients with bronchiectasis not related to cystic fibrosis (non-CF bronchiectasis). Methods: One hundred and thirty-five non-CF bronchiectasis inpatients, allocated to a 3-week PR program, were retrospectively evaluated. Exercise capacity (6-min walk distance, 6MWD), dyspnea (Baseline/Transition Dyspnea Index, BDI/TDI), and HRQoL [EuroQol visual analogue scale (EQ-VAS)] were assessed before and after PR. The relationship between baseline parameters and changes in outcome measures after PR was assessed. Both univariate and multiple logistic analyses were performed to evaluate the presence of independent predictors of the efficacy of PR. Results: One hundred and eight patients [49 males, mean age 71 years, mean forced expiratory volume in 1 s (FEV1) 76{\%} predicted] were included. After PR, there was a significant improvement in 6MWD, TDI, and EQ-VAS score (p <0.001). Changes in 6MWD and EQ-VAS score correlated with baseline FEV1, FEV1/vital capacity (VC), residual volume, transfer factor of the lung for carbon monoxide, and the number of exacerbations in the previous year. Both univariate and multivariate logistic regression analyses showed that male gender, baseline FEV1/VC 2 exacerbations in the previous year were independent predictors of PR efficacy in terms of an improvement in 6MWD. Conclusions: Our study supports the inclusion of patients with bronchiectasis in PR programs. Clinical and functional baseline findings partially predict the response to PR in terms of exercise tolerance. Further prospective, randomized, controlled trials are needed.",
keywords = "Bronchiectasis, Predictors of efficacy, Pulmonary rehabilitation",
author = "Andrea Zanini and Marina Aiello and Daniela Adamo and Francesca Cherubino and Elisabetta Zampogna and Giovanni Sotgiu and Alfredo Chetta and Antonio Spanevello",
year = "2015",
month = "7",
day = "22",
doi = "10.1159/000380771",
language = "English",
volume = "89",
pages = "525--533",
journal = "Respiration; international review of thoracic diseases",
issn = "0025-7931",
publisher = "S. Karger AG",
number = "6",

}

TY - JOUR

T1 - Effects of Pulmonary Rehabilitation in Patients with Non-Cystic Fibrosis Bronchiectasis

T2 - A Retrospective Analysis of Clinical and Functional Predictors of Efficacy

AU - Zanini, Andrea

AU - Aiello, Marina

AU - Adamo, Daniela

AU - Cherubino, Francesca

AU - Zampogna, Elisabetta

AU - Sotgiu, Giovanni

AU - Chetta, Alfredo

AU - Spanevello, Antonio

PY - 2015/7/22

Y1 - 2015/7/22

N2 - Background: International guidelines recommend the inclusion of patients with bronchiectasis in pulmonary rehabilitation (PR) to improve exercise capacity and health-related quality of life (HRQoL). At present, the effect of PR in these patients has been poorly investigated. Objective: The aim of our retrospective analysis was to evaluate the effects and predictors of success for a PR program in patients with bronchiectasis not related to cystic fibrosis (non-CF bronchiectasis). Methods: One hundred and thirty-five non-CF bronchiectasis inpatients, allocated to a 3-week PR program, were retrospectively evaluated. Exercise capacity (6-min walk distance, 6MWD), dyspnea (Baseline/Transition Dyspnea Index, BDI/TDI), and HRQoL [EuroQol visual analogue scale (EQ-VAS)] were assessed before and after PR. The relationship between baseline parameters and changes in outcome measures after PR was assessed. Both univariate and multiple logistic analyses were performed to evaluate the presence of independent predictors of the efficacy of PR. Results: One hundred and eight patients [49 males, mean age 71 years, mean forced expiratory volume in 1 s (FEV1) 76% predicted] were included. After PR, there was a significant improvement in 6MWD, TDI, and EQ-VAS score (p <0.001). Changes in 6MWD and EQ-VAS score correlated with baseline FEV1, FEV1/vital capacity (VC), residual volume, transfer factor of the lung for carbon monoxide, and the number of exacerbations in the previous year. Both univariate and multivariate logistic regression analyses showed that male gender, baseline FEV1/VC 2 exacerbations in the previous year were independent predictors of PR efficacy in terms of an improvement in 6MWD. Conclusions: Our study supports the inclusion of patients with bronchiectasis in PR programs. Clinical and functional baseline findings partially predict the response to PR in terms of exercise tolerance. Further prospective, randomized, controlled trials are needed.

AB - Background: International guidelines recommend the inclusion of patients with bronchiectasis in pulmonary rehabilitation (PR) to improve exercise capacity and health-related quality of life (HRQoL). At present, the effect of PR in these patients has been poorly investigated. Objective: The aim of our retrospective analysis was to evaluate the effects and predictors of success for a PR program in patients with bronchiectasis not related to cystic fibrosis (non-CF bronchiectasis). Methods: One hundred and thirty-five non-CF bronchiectasis inpatients, allocated to a 3-week PR program, were retrospectively evaluated. Exercise capacity (6-min walk distance, 6MWD), dyspnea (Baseline/Transition Dyspnea Index, BDI/TDI), and HRQoL [EuroQol visual analogue scale (EQ-VAS)] were assessed before and after PR. The relationship between baseline parameters and changes in outcome measures after PR was assessed. Both univariate and multiple logistic analyses were performed to evaluate the presence of independent predictors of the efficacy of PR. Results: One hundred and eight patients [49 males, mean age 71 years, mean forced expiratory volume in 1 s (FEV1) 76% predicted] were included. After PR, there was a significant improvement in 6MWD, TDI, and EQ-VAS score (p <0.001). Changes in 6MWD and EQ-VAS score correlated with baseline FEV1, FEV1/vital capacity (VC), residual volume, transfer factor of the lung for carbon monoxide, and the number of exacerbations in the previous year. Both univariate and multivariate logistic regression analyses showed that male gender, baseline FEV1/VC 2 exacerbations in the previous year were independent predictors of PR efficacy in terms of an improvement in 6MWD. Conclusions: Our study supports the inclusion of patients with bronchiectasis in PR programs. Clinical and functional baseline findings partially predict the response to PR in terms of exercise tolerance. Further prospective, randomized, controlled trials are needed.

KW - Bronchiectasis

KW - Predictors of efficacy

KW - Pulmonary rehabilitation

UR - http://www.scopus.com/inward/record.url?scp=84937516705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937516705&partnerID=8YFLogxK

U2 - 10.1159/000380771

DO - 10.1159/000380771

M3 - Article

VL - 89

SP - 525

EP - 533

JO - Respiration; international review of thoracic diseases

JF - Respiration; international review of thoracic diseases

SN - 0025-7931

IS - 6

ER -